DNA damaging therapies in patients (pts) with prostate cancer (PC) and pathogenic alterations in homologous recombination repair (HRR) genes.
Laura Graham, Edward Green,Joseph J. Park,Olesia Kellezi,Clara Hwang,Pedro C. Barata,Mehmet Asim Bilen,Deepak Kilari,Melissa Clingerman,Abhishek Tripathi,Matthew Labriola,Shoshana Rothstein,Rohan Garje,Vadim S. Koshkin,Vaibhav G. Patel,Tanya B. Dorff,Andrew J. Armstrong,Rana R. Mckay,Ajjai Shivaram Alva,Michael Thomas Schweizer JOURNAL OF CLINICAL ONCOLOGY（2022）
AI 理解论文
溯源树
样例
